- Display 30 Products per page
Published: November 1, 2007 | Price: $1,995.00 – $3,990.00
No longer is cell-based diagnostics simply a histological study of biopsied and surgical tissues. Combinations of tests and technologies are coming together to create a new map of cell diagnostics. Image cytometry, microfluidics, microarrays, and biosensors, special immunohistochemical and in situ hybridization probes are creating new approaches to cell and tissue observation, diagnostics and pharmacogenomics. This report covers assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood,...Published: July 1, 2007 | Price: $995.00 – $3,990.00
In light of laboratory pressures to do more with less, laboratory managers transfer cost control onto vendors by means of a constant push for price reductions. In this commercial climate, efficient management of customer and technical service extras is critical. Expertise in managing service offerings will help companies offer service programs that are just enough to differentiate them from the competition. Service programs that offer too much may result in revenue loss. Programs that are perceived to be inadequate place...Published: May 1, 2007 | Price: $2,995.00 – $5,990.00
Molecular imaging maps the locations of specific molecules and biomaterials within living tissue. As such, it has the potential to diagnose a disease, to monitor the course of that disease, and possibly facilitate treatment. Molecular imaging has developed into a promising new strategy for the diagnosis, evaluation and treatment of disease. The final volume in Kalorama's Medical Imaging Markets series: Medical Imaging Markets, Volume V, Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the...Published: May 1, 2007 | Price: $2,995.00 – $5,990.00
Many in the clinical and manufacturing community have their eyes on the Physician Office Laboratory (POL) as an outlet both to improve patient compliance and outcomes and to open new market opportunities. Studies are emerging on the clinical outcomes and cost-benefit of nearer-the-patient testing, but little certain is known about POLs as a distribution channel for diagnostics products. Kalorama's Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends takes a bold look into the technologies and trends...Published: February 1, 2007 | Price: $1,995.00 – $3,990.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, offer dramatic benefits in the diagnostic process that point towards a robust market. LF tests are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and manufacturing. Rapid point of care testing devices will play an increasingly important role in the decentralization of medicine, where testing is moving away...Published: February 1, 2007 | Price: $1,995.00 – $5,990.00
Contrast agents and radiopharmaceuticals have revolutionized in vivo imaging. Technical developments in contrast media and imaging techniques is combining with the trends toward both the functional and molecular understanding of disease to create a rapidly growing marketplace in these agents. The introduction and now brisk ongoing development of contrast media for traditional radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron-emission tomography (PET), and single-photon emission computed tomography (SPECT), are now allowing for the expansion of diagnostic capabilities of...Published: December 1, 2006 | Price: $4,500.00 – $9,990.00
The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices become established. This comprehensive report on the market for clinical in vitro diagnostic (IVD) tests in India covers both reagent and instrumentation markets for the...Published: November 1, 2006 | Price: $2,995.00 – $5,990.00
Collectively, the techniques of photon-based experimental manipulation and advanced optical imaging define the field of biophotonics. There are several key areas that are associated with biophotonics. All of these center on microscopy and related technology. The reason that this is so is that biophotonics look at biological functions at the cellular level, or even smaller. The only way that these processes can be observed is via one or another form of microscopy. Among the different types of microscopy and associated...Published: November 1, 2006 | Price: $1,500.00 – $5,990.00
This report takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. There is also an emphasis on early disease detection via rapid test use in clinics and public venues. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place. The field for rapid test devices is crowded; worldwide,...Published: October 1, 2006 | Price: $1,200.00 – $5,990.00
Ultrasound, also known as sonography, is not a new imaging modality—having been around since the 1950s—but its application areas have just recently begun to expand tremendously. These new clinical applications, along with technological innovations in portability and resolution and a very favorable risk profile, have made ultrasound equipment a very robust market sector. This third volume in Kalorama’s ongoing series on medical imaging examines the market for ultrasound equipment worldwide, reviewing the drivers and restraints, the established and emerging application...Published: September 1, 2006 | Price: $1,995.00 – $7,800.00
This comprehensive evaluation of the blood industry provides an analysis of all the key market segments involved in this industry, including blood products such as: Red Blood Cells (RBCs) Immunoglobulins Albumin Other Plasma Products Synthetic HBOC and PFC Agents Recombinant Factors And blood supply management products, including: Blood Collection Equipment Automated Blood Collection Equipment Blood Banking and Plasmapheresis Testing Blood Typing Human Immunodeficiency Virus (HIV) Testing Hepatitis A Virus Testing Hepatitis B Virus Testing Hepatitis C Virus Testing Human T-Cell...Published: April 1, 2006 | Price: $3,900.00 – $7,800.00
This completely updated edition of Kalorama’s comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all areas of IVD, including: Point-of-Care Clinical Chemistry Immunoassays Molecular Assays Hematology Coagulation Microbiology and Virology Blood Banking Histology and Cytology Market size, growth, share, and geographic distribution, as well as trends in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Projections are made through 2010. This new 1,000-page...Published: March 1, 2006 | Price: $3,000.00 – $6,000.00
This report on the U.S. market for over-the-counter (OTC) pediatric medications presents an in-depth analysis of the performance of non-prescription pediatric drugs and other selected pediatric healthcare products in the marketplace. The analysis captures the performance of the market players, categories, and leading brands in terms of revenue growth and volume growth in several categories of medication, including cough/cold allergy sinus products; first aid products; internal analgesic products, and other pediatric products (chest rubs, nasal products and bedwetting remedies). In...Published: November 1, 2005 | Price: $4,995.00 – $9,990.00
There has not been a year in the last decade in which the IVD market in China has failed to grow. With a gross domestic product of over $1.4 trillion, China surpassed Italy last year to become the world’s sixth largest economy, according to the International Monetary Fund. This country of 1.3 billion people is now America’s sixth largest export market, and China’s economy, which has been growing at an average rate of 8% over the last 20 years, grew...Published: June 1, 2005 | Price: $995.00 – $1,990.00
In addition to being one of the most important tissues in the body, blood has emerged as a key vector in the transmission of the world's deadliest infectious diseases. With the rising demand for transfusions in a variety of conditions such as anemias, trauma, and high-blood-loss surgeries, supplies have been stretched and the dangers of disease transmission have added significant cost pressures to maintaining a safe supply. One possible solution to ease the crunch, particularly in acute amergency care settings...Published: June 1, 2005 | Price: $995.00 – $1,990.00
Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis. Research groups around the world are joining the effort to use magnetic, nuclear, and optical imaging techniques to study the molecular interactions that underlie biological processes. This market briefing presents an overview of the market for molecular imaging agents and systems. The briefing provides an introduction to molecular imaging modalities and applications, and focuses on imaging agents...Published: January 1, 2005 | Price: $3,500.00 – $7,000.00
The concept of nucleic acid-based therapeutics is not a new one. For a long time it has been thought that molecules similar to those that make up our genetic structure would make effective therapeutics. It is an idea whose time has come. There are six types of nucleic acid-based therapeutics that have been proposed. Some have made it to market, others are still in development, and some have been put on the back burner due to technical difficulties. The six...Published: January 1, 2005 | Price: $3,500.00 – $7,000.00
This report covers clinical and drug discovery assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood, bone marrow, urine, cerebrospinal and other body fluids and tissue samples. Cell analysis is not a new laboratory procedure. Clinical diagnostics using cells and tissues is one of the oldest disciplines in laboratory medicine. Histological study of biopsy samples, the complete blood count, and the enumeration of disease-bearing cells have been...Published: November 15, 2004 | Price: $4,995.00 – $9,990.00
This unprecedented study provides detailed market data on products and segments in the retail OTC diagnostic market in the United States. In addition to market size, growth and competitive share information on each of six testing categories plus testing accessories, the report contains the results of a major consumer survey conducted jointly by Kalorama Information and The Telephone Centre, Inc., focusing on consumer attitudes and awareness of OTC testing products and their marketing channels. This valuable consumer information, never before...Published: October 1, 2004 | Price: $995.00 – $1,990.00
Currently, the largest market application segment for molecular diagnostics is that for infectious disease testing. The segment is expected to grow at an annual rate between 7% and 8% over the next few years will present some excellent market opportunites for molecular diagnostic competitors. This summary report, extracted from Kalorama Information’s U.S. Market for Molecular Diagnostics, (2nd Edition, May 2004), focuses on the technologies and application of molecular diagnostics in the field of infectious disease testing. The major market effects...Published: October 1, 2004 | Price: $995.00 – $1,990.00
Gene and chromosome testing for inherited diseases currently represents the third largest molecular diagnostics testing segment in the U.S. Assays in this market address applications in genetic carrier and predisposition testing. Currently, most testing is for prenatal screening and for assessing clinically suspect newborns for various chromosomal abnormalities (e.g., Down’s syndrome, fragile X syndrome). Some testing is used for genetic counseling for couples planning to have children. Such diagnostics test for the presence of carrier states of diseases such as...Published: October 1, 2004 | Price: $995.00 – $1,990.00
The field of pharmacogenetics promises to open up new opportunities for the diagnostic industry at the same time it opens the door to more effective therapeutics. Pharmacogenetics is based on the principle that the effects of a given medication when administered to a patient are determined, at least in part, by his or her genetic constitution. Differences in drug metabolism may lead to varying adverse events or more pronounced adverse events in different individuals, and differing metabolism may also lead...Published: May 1, 2004 | Price: $3,500.00 – $7,000.00
Molecular diagnostics are seen as being a major breakthrough in medical science. While the technology itself has broad applications to such areas as agricultural bioterrorism and environmental science, medical and medical research applications have provided the primary focus. As a result, great things have been predicted for the development and use of new therapeutics based on molecular testing approaches. The primary molecular diagnostics approaches are based on two major database sciences (genomics and proteomics) and their relationship to disease and...Published: April 1, 2004 | Price: $1,995.00 – $3,990.00
The recent terrorism events, in addition to the ease of travel that allows infectious diseases to spread, and technology developments drive the renewed interest in clinical and environmental infectious disease diagnostics. The combined public health and bio-terrorism markets of several bacterial and protozoan diseases are estimated to be nearly $100 million. This report, the final volume of the Diagnostics for Emerging Infectious Disease Threats series, focuses on diagnostic testing for 11 bacterial and protozoal diseases in clinical and environmental testing:...Published: April 1, 2004 | Price: $3,500.00 – $7,000.00
Changing demographics are spurring dynamic growth in the interventional radiology market. The angioplasty balloon, coronary stent, vascular closure, and other associated equipment markets will experience healthy growth over the next 5 years. Persons over the age of 65 will be a major segment of the population in coming years. Chronic diseases and unhealthy habits such as smoking, lack of exercise, and poor diet are resulting in an epidemic of obesity and concomitant cardiac conditions. These factors and others will drive...Published: March 1, 2004 | Price: $3,995.00 – $7,990.00
A host of new and old infectious diseases have emerged on the world stage, presenting familiar and novel challenges to public health officials. New strains of once controlled bacteria, new immunocomprimised patient populations, and new bioterror threats have spurred diagnostics companies to develop new tests and kits to meet the demand. Kalorama has assembled the vital data developers and marketers need to understand the competitive and commercial landscape in three volumes: Prion Disease; Viral Disease ; and Baterial & Protozoal...Published: December 1, 2003 | Price: $1,496.00 – $2,992.00
Severe Acute Respiratory Syndrome (SARS), which was a new and unidentified disease when it first affected people, ripped through Asia and Toronto from late 2002 into the summer of 2003, before being contained for the season. Taiwan with just 346 reported cases performed 10,000 diagnostic tests. Three years after West Nile Virus (WNV) first appeared in the United States in 1999 with just 62 cases and 7 deaths, the U.S. Center for Disease Control reports thousands of cases and 150...Published: October 1, 2003 | Price: $1,496.00 – $2,992.00
Diagnostic testing for prion diseases has become more important as countries increase the number of tests to battle the potential public health problem. Academic, government, and industry organizations continue to develop diagnostic testing technologies and policies as preventative measures. The number of prion diagnostic technologies being used and developed for prion diseases primarily reflects the scientific and technical challenges of detecting prion proteins. Growth of prion testing will depend on these technology breakthroughs and the future prevalence of prion disease....Published: May 1, 2003 | Price: $2,625.00 – $5,250.00
Genetic testing is already in widespread use and will continue to grow in many application areas in the next five years. The number of companies offering genetic testing services and/or commercial genetic testing products continues to grow around the world. There are at least 50 companies offering genetic testing services or commercial products for a genetic test in medical, GMO food safety, forensics, and paternity applications. In the area of medical genetics, tests and services can vary by disease. Under...Published: February 1, 2003 | Price: $596.00 – $1,192.00
To succeed in the diagnostics market of the 21st Century, a company has to have either a strong niche position in a particular market segment or be a jack of all trades. In either case, a full or comprehensive menu is critical. Why reinvent the wheel? Most tests and systems are already available somewhere, offered by reputable companies with a strong R&D background. This report is designed to provide a window on IVD market and product opportunities available outside North...